We found overall fewer vessels in both early and delayed IV treatment group, with reduced EES, laminin, and αSMA staining, especially at the invasive margin of the tumor indicating the role of HET0016 in inhibiting the growth of new blood vessels. The gene discussed is ACTA1; the disease is neoplasm.